Drugs / Mycophenoate Mofetil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02686619 Background | Nov 2004 → Jan 2011 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mycophenoate Mofetil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02686619 ↗ |
| Route | Oral | “daily dose of 2 g) orally for 12 months.” NCT02686619 ↗ |